SEARCH

SEARCH BY CITATION

References

  • 1
    Hilton E, Edwards B, Singer C. Reported illness and compliance in US travelers attending an immunization facility. Arch Intern Med 1989; 149: 178179. 2912406
  • 2
    Gyorkos TW, Svenson JE, Maclean JD et al. Compliance with antimalarial chemoprophylaxis and the subsequent development of malaria: a matched case—control study. Am J Trop Med Hyg 1995; 53: 511517. 7485709
  • 3
    Aalbersberg P, van Berkel J, Stokvis H. Dutch travelers to developing countries: disease prevention and effects on morbidity. Trav Med 1991; 2: 5557.
  • 4
    Breckenridge A. Risks and benefits of prophylactic antimalaria drugs. BMJ 1989; 299: 10571058. 2511961
  • 5
    Held TK, Weinke T, Mansmann U et al. Malaria prophylaxis: identifying risk groups for non compliance. Q J Med 1994; 87: 1722. 8140213
  • 6
    Steffen R, Heuser R, Mächler B. Malaria chemoprophylaxis among European tourists in tropical Africa: use, adverse reactions and efficacy. Bull WHO 1990; 68: 312322.
  • 7
    Direction générale de la santé. Actualisation des recommandations sanitaires pour les voyageurs. Bull Epidemiol Hebd 1995; 18: 7881.
  • 8
    WHO. International Travel and Health 1995 Geneva WHO.